KEMPHARM, INC Business Finance Contracts & Agreements
72 Contracts & Agreements
- Credit Agreements (1 contract)
- Equity Distribution Agreements (2)
- Exchange Agreements (7)
- Facility Agreements (13)
- Guaranty Agreements (1)
- Indenture Agreements (1)
- Joinder Agreements (2)
- Loan Agreements (4)
- Note Agreements (6)
- Purchase Agreements (5)
- Registration Rights Agreements (4)
- Stock Agreements (4)
- Term Sheets (2)
- Underwriting Agreements (5)
- Warrant Agreements (15)
- Underwriting Agreement, dated as of August 8, 2024, by and between Zevra Therapeutics, Inc. and Cantor Fitzgerald & Co. and William Blair & Company, L.L.C (Filed With SEC on August 9, 2024)
- Equity Distribution Agreement, dated as of July 12, 2024, by and between Zevra Therapeutics, Inc. and Citizens JMP Securities, LLC (Filed With SEC on July 12, 2024)
- CREDIT AGREEMENT Dated as of April 5, 2024 among ZEVRA THERAPEUTICS, INC., as the Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER, as Guarantors, ALTER DOMUS (US) LLC, as the... (Filed With SEC on May 9, 2024)
- First Amendment to the Bridge Loan Agreement by and between the Registrant and Acer Therapeutics Inc (Filed With SEC on April 1, 2024)
- Form of Warrant (Filed With SEC on November 20, 2023)
- Registration Rights Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and each of the sellers party thereto (Filed With SEC on August 31, 2023)
- Note Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (Filed With SEC on August 31, 2023)
- Loan Purchase Agreement dated as of August 30, 2023 by and among Zevra Therapeutics, Inc., and Nantahala Capital Management, LLC and the other sellers party thereto (Filed With SEC on August 31, 2023)
- Bridge Loan Agreement dated as of August 30, 2023 by and between Zevra Therapeutics, Inc. and Acer Therapeutics Inc (Filed With SEC on August 31, 2023)
- Revolving Loan Agreement dated May 31, 2022 by and among KemPharm, Inc. and Ameris Bank, as lender (Filed With SEC on June 1, 2022)
- Asset Purchase Agreement by and among KemPharm, Inc., KemPharm Denmark A/S and Orphazyme A/S in restructuring, dated May 15, 2022 (Filed With SEC on May 16, 2022)
- 2021 Employee Stock Purchase Plan (Filed With SEC on August 13, 2021)
- Equity Distribution Agreement, dated July 2, 2021, by and among KemPharm, Inc., JMP Securities LLC and RBC Capital Markets, LLC (Filed With SEC on July 2, 2021)
- Form of Inducement Warrant (Filed With SEC on June 23, 2021)
- Specimen stock certificate evidencing shares of Common Stock (Filed With SEC on March 12, 2021)
- Form of Inducement Warrant (Filed With SEC on January 26, 2021)
- Amendment to Senior Secured Convertible Notes and Amendment to Warrant, dated as of January 12, 2021, by and among the Company, Deerfield Private Design Fund III, L.P. and... (Filed With SEC on January 13, 2021)
- Series A Common Stock Purchase Warrant for Underwriter (Filed With SEC on January 13, 2021)
- Form of Common Stock Purchase Warrant and schedule of holders (Filed With SEC on January 13, 2021)
- Form of Underwriting Agreement (Filed With SEC on January 5, 2021)
- Joinder Agreement, dated as of December 23, 2020, by and between KemPharm, Inc. and M. Kingdon Offshore Master Fund, LP (Filed With SEC on December 28, 2020)
- Joinder Agreement, dated as of December 23, 2020, by and between KemPharm, Inc. and Delaware Street Capital Master Fund, L.P (Filed With SEC on December 28, 2020)
- Amendment to Facility Agreement, Notes and to December 2020 Exchange Agreement, dated as of December 24, 2020, by and among KemPharm, Inc., Deerfield Private Design Fund III, L.P.... (Filed With SEC on December 28, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on December 21, 2020)
- Form of Common Stock Warrant (Filed With SEC on December 21, 2020)
- Form of Underwriting Agreement (Filed With SEC on December 21, 2020)
- December 2020 Exchange Agreement and Amendment to Facility Agreement, Notes and Investors Rights Agreement, dated as of December 20, 2020, by and among KemPharm, Inc., Deerfield... (Filed With SEC on December 21, 2020)
- Registration Rights Agreement dated February 28, 2019 by and between the Company and Lincoln Park Capital Fund, LLC (incorporated herein by reference to the Registrant's Annual... (Filed With SEC on February 28, 2020)
- Amendment to Senior Secured Convertible Notes and Amendment to Warrant, dated as of February 17, 2020, by and among KemPharm, Inc. and the noteholders party thereto (Filed With SEC on February 18, 2020)
- Registration Rights Agreement, dated as of February 17, 2020, by and between KemPharm, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)
- Purchase Agreement, dated as of February 17, 2020, by and between KemPharm, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on February 18, 2020)
- Amendment to December 2019 Notes and Consent, dated as of January 12, 2020, by and among KemPharm, Inc. and the signatories party thereto (Filed With SEC on January 13, 2020)
- Senior Secured Convertible Note, dated as of January 13, 2020 (Filed With SEC on January 13, 2020)
- January 2020 Exchange Agreement, dated as of January 12, 2020, by and between KemPharm, Inc. and M. Kingdon Offshore Master Fund, LP (Filed With SEC on January 13, 2020)
- Amended and Restated Guaranty and Security Agreement, dated as of December 18, 2019, by and among KemPharm, Inc., each other Grantor party thereto, each Guarantor party thereto... (Filed With SEC on December 18, 2019)
- Amended and Restated Senior Secured Convertible Note issued to Deerfield Private Design Fund III, L.P., dated as of December 18, 2019 (Filed With SEC on December 18, 2019)
- Form of Senior Secured Convertible Note, with a schedule of noteholders (Filed With SEC on December 18, 2019)
- Amendment to September 2019 Exchange Agreement and Amendment to Facility Agreement, dated as of December 17, 2019, by and among KemPharm, Inc., Deerfield Private Design Fund III,... (Filed With SEC on December 18, 2019)
- December 2019 Exchange Agreement and Amendment to Facility Agreement, Senior Secured Convertible Notes and Warrants, dated as of December 17, 2019, by and among KemPharm, Inc.,... (Filed With SEC on December 18, 2019)
- Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 30, 2019 (Filed With SEC on November 14, 2019)
